Fentanyl Citrate Injection
Brand names: Fentanyl Citrate
Category: Analgesia/Addiction, Pediatric
Unavailable 4Limited 3Available 12
FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: Jan 1, 2012 (in shortage 14 years 9 months) · 3 manufacturers, 19 listed presentations
As of Sep 22, 2026, the FDA lists Fentanyl Citrate Injection as currently in shortage. Of 19 manufacturer presentations, 4 Unavailable, 3 Limited, 12 Available.
Ask your pharmacist: which of the 3 manufacturers below can they order right now, and whether a different strength or form of Fentanyl Citrate Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) NDC 63323-806-02 |
Fresenius Kabi USA, LLC | Unavailable | Next release September 2026. Check wholesalers for inventory. |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) NDC 63323-806-01 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) NDC 63323-806-50 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) NDC 63323-806-20 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) NDC 63323-806-05 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) NDC 0641-6027-25 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) NDC 0641-6247-25 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) NDC 0641-6028-25 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) NDC 0641-6029-25 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) NDC 0641-6030-01 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) NDC 0641-6024-10 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Inventory available in vial presentations. |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) NDC 0641-6025-10 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Inventory available in vial presentations. |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) NDC 0641-6026-05 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Inventory available in vial presentations. |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) NDC 63323-808-11 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) NDC 0409-9094-22 |
Hospira, Inc., a Pfizer Company | Available | - |
| Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) NDC 0409-9094-31 |
Hospira, Inc., a Pfizer Company | Limited | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026 |
| Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) NDC 0409-9094-25 |
Hospira, Inc., a Pfizer Company | Limited | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 |
| Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) NDC 0409-9094-61 |
Hospira, Inc., a Pfizer Company | Available | - |
| Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) NDC 0409-9094-28 |
Hospira, Inc., a Pfizer Company | Limited | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026 |
Related medications in shortage
Other Analgesia/Addiction, Pediatric medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Fentanyl Citrate Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Fentanyl Citrate Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Check your inbox - click the confirmation link to activate
alerts for Fentanyl Citrate Injection.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/fentanyl-citrate-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).